These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11844866)

  • 21. Tackling anthrax.
    Friedlander AM
    Nature; 2001 Nov; 414(6860):160-1. PubMed ID: 11700539
    [No Abstract]   [Full Text] [Related]  

  • 22. How anthrax kills.
    Hanna P
    Science; 1998 Jun; 280(5370):1671, 1673-4. PubMed ID: 9660700
    [No Abstract]   [Full Text] [Related]  

  • 23. Three steps to targeting anthrax toxin.
    Lindsay J
    Trends Mol Med; 2002 Jan; 8(1):6. PubMed ID: 11796256
    [No Abstract]   [Full Text] [Related]  

  • 24. The roles of anthrax toxin in pathogenesis.
    Moayeri M; Leppla SH
    Curr Opin Microbiol; 2004 Feb; 7(1):19-24. PubMed ID: 15036135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of small molecule inhibitors of anthrax lethal factor.
    Panchal RG; Hermone AR; Nguyen TL; Wong TY; Schwarzenbacher R; Schmidt J; Lane D; McGrath C; Turk BE; Burnett J; Aman MJ; Little S; Sausville EA; Zaharevitz DW; Cantley LC; Liddington RC; Gussio R; Bavari S
    Nat Struct Mol Biol; 2004 Jan; 11(1):67-72. PubMed ID: 14718925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative Determination of Lethal Toxin Proteins in Culture Supernatant of Human Live Anthrax Vaccine Bacillus anthracis A16R.
    Zai X; Zhang J; Liu J; Liu J; Li L; Yin Y; Fu L; Xu J; Chen W
    Toxins (Basel); 2016 Feb; 8(3):. PubMed ID: 26927174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection of farm goats by combinations of recombinant peptides and formalin inactivated spores from a lethal Bacillus anthracis challenge under field conditions.
    Koehler SM; Buyuk F; Celebi O; Demiraslan H; Doganay M; Sahin M; Moehring J; Ndumnego OC; Otlu S; van Heerden H; Beyer W
    BMC Vet Res; 2017 Jul; 13(1):220. PubMed ID: 28701192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A dominant-negative therapy for anthrax.
    Leppla SH
    Nat Med; 2001 Jun; 7(6):659-60. PubMed ID: 11385497
    [No Abstract]   [Full Text] [Related]  

  • 29. Passive Immunotherapy Protects against Enteric Invasion and Lethal Sepsis in a Murine Model of Gastrointestinal Anthrax.
    Huang B; Xie T; Rotstein D; Fang H; Frucht DM
    Toxins (Basel); 2015 Sep; 7(10):3960-76. PubMed ID: 26426050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ratio of lethal and edema factors in rabbit systemic anthrax.
    Molin FD; Fasanella A; Simonato M; Garofolo G; Montecucco C; Tonello F
    Toxicon; 2008 Dec; 52(7):824-8. PubMed ID: 18812184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Infections by Bacillus anthracis].
    Biederbick W; Fock R; Güttler K; Veit C
    Dtsch Med Wochenschr; 2002 Apr; 127(15):809-14. PubMed ID: 11951140
    [No Abstract]   [Full Text] [Related]  

  • 32. Transcriptional stimulation of anthrax toxin receptors by anthrax edema toxin and Bacillus anthracis Sterne spore.
    Xu Q; Hesek ED; Zeng M
    Microb Pathog; 2007 Jul; 43(1):37-45. PubMed ID: 17459655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibody against the poly-gamma-D-glutamic acid capsule of Bacillus anthracis protects mice from enhanced lethal toxin activity due to capsule and anthrax spore challenge.
    Jang J; Cho M; Lee HR; Cha K; Chun JH; Hong KJ; Park J; Rhie GE
    Biochim Biophys Acta; 2013 Mar; 1830(3):2804-12. PubMed ID: 23201204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacillus anthracis.
    Spencer RC
    J Clin Pathol; 2003 Mar; 56(3):182-7. PubMed ID: 12610093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anthrax capsule vaccine protects against experimental infection.
    Chabot DJ; Scorpio A; Tobery SA; Little SF; Norris SL; Friedlander AM
    Vaccine; 2004 Nov; 23(1):43-7. PubMed ID: 15519706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions between anthrax toxin receptors and protective antigen.
    Scobie HM; Young JA
    Curr Opin Microbiol; 2005 Feb; 8(1):106-12. PubMed ID: 15694864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunisation with anthrolysin O or a genetic toxoid protects against challenge with the toxin but not against Bacillus anthracis.
    Cowan GJ; Atkins HS; Johnson LK; Titball RW; Mitchell TJ
    Vaccine; 2007 Oct; 25(41):7197-205. PubMed ID: 17765365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in the development of next-generation anthrax vaccines.
    Friedlander AM; Little SF
    Vaccine; 2009 Nov; 27 Suppl 4():D28-32. PubMed ID: 19837282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anthrax: clinical features, pathogenesis, and potential biological warfare threat.
    Friedlander AM
    Curr Clin Top Infect Dis; 2000; 20():335-49. PubMed ID: 10943532
    [No Abstract]   [Full Text] [Related]  

  • 40. Anthrax Toxins in Context of Bacillus anthracis Spores and Spore Germination.
    Cote CK; Welkos SL
    Toxins (Basel); 2015 Aug; 7(8):3167-78. PubMed ID: 26287244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.